3/A//SEC Filing
JK BioPharma Solutions, Inc 3/A
Accession 0001683168-20-000182
CIK 0001638287other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 2:34 PM ET
Size
15.9 KB
Accession
0001683168-20-000182
Insider Transaction Report
Form 3/AAmended
Kang Sun Dae
10% Owner
Holdings
- 800,170
Common Stock
- 1,817,842
Common Stock
JK BioPharma Solutions, Inc
10% Owner
Holdings
- 1,817,842
Common Stock
- 800,170
Common Stock
Footnotes (2)
- [F1]These shares are owned directly by JK BioPharma Solutions, Inc., a 10% owner of the Issuer, and indirectly by Dr. Sun Dae Kang, as director of JK BioPharma Solutions, Inc. Dr. Kang disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]These shares are owned directly by Dr. Sun Dae Kang.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001590304
Filing Metadata
- Form type
- 3/A
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 2:34 PM ET
- Size
- 15.9 KB